InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,226.40
(
0.10%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.64
(
0.73%
)
Bitcoin
62,818.42
(
-0.54%
)
Post# of 252311
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

rfj1862

Send PM Follow Ignore
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

rfj1862

Re: None

Wednesday, 07/10/2019 12:09:59 PM

Wednesday, July 10, 2019 12:09:59 PM

Post# of 252311
MRKR

Pancreatic data being presented on Saturday, Jul 20 2019 at an AACR meeting during the plenary from 8 to 10 am.

Investor event to follow on Monday July 22 at 1:30 PM.

This is not *really* a binary event for MRKR; all valuations are based on efficacy in hematologic cancers, but if this is positive in a solid tumor (as the fact that AACR granted a plenary would suggest) then there is a ton of upside beyond the potential hematologic indications.

https://www.prnewswire.com/news-releases/marker-therapeutics-to-report-updated-results-from-phase-12-trial-with-multitaa-therapy-in-patients-with-pancreatic-adenocarcinoma-300871612.html
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up